Postdoctoral Scientist – Advanced Image Analysis
Eli Lilly and Company
Summary
The Advanced Image Analysis Group uses imaging to generate clinically meaningful endpoints. We develop and deploy imaging biomarkers that help guide critical decisions across stages of clinical development. Our team brings deep expertise in multi-modal imaging and pioneers imaging endpoints that help advance new medicines for patients. We design imaging programs from early studies through late-phase trials, and our science contributes to future therapies.
Job description
Organization Overview
The Advanced Image Analysis Group uses imaging to generate clinically meaningful endpoints. We develop and deploy imaging biomarkers that help guide critical decisions across stages of clinical development. Our team brings deep expertise in multi-modal imaging and pioneers imaging endpoints that help advance new medicines for patients. We design imaging programs from early studies through late-phase trials, and our science contributes to future therapies.
Responsibilities
As a postdoctoral scientist in the Advanced Image Analysis Group, you will develop novel AI-driven brain image analysis methods and endpoints for neurodegeneration research and therapeutic development. Your work will inform clinical development decisions as part of a collaborative, cross-functional team. In this role, you will:
- Design, develop, and implement AI-driven image analysis methods for brain PET and MRI endpoints.
- Process and analyze PET and MRI data and improve existing analysis pipelines to increase efficiency.
- Collaborate with cross-functional internal teams and external partners to support the development and validation of imaging endpoints.
- Integrate and harmonize multi-modal imaging data to support research objectives.
- Present findings at scientific conferences and publish manuscripts in peer-reviewed journals.
- Stay current with advances in AI and medical imaging and apply them to the team’s research.
Basic Requirements
PhD in biomedical imaging, computer science, biomedical or computer engineering, or a related field.
Additional Skills/Preferences
- Experience in medical image analysis, particularly MRI and PET, and in developing AI-driven brain imaging endpoints.
- Experience in programming and deep learning.
- Record of peer-reviewed publications in medical image analysis, AI, or a related field.
- Demonstrated initiative in learning new techniques and advancing independent research.
- Strong written and oral communication skills, including experience presenting at scientific conferences.
- Experience in clinical neurodegeneration image analysis.
- Experience in developing or customizing image analysis software.
- Travel: 5–10%
Requirements
- PhD in biomedical imaging, computer science, biomedical or computer engineering, or a related field
- Experience in medical image analysis, particularly MRI and PET, and in developing AI-driven brain imaging endpoints
- Experience in programming and deep learning
- Record of peer-reviewed publications in medical image analysis, AI, or a related field
- Demonstrated initiative in learning new techniques and advancing independent research
- Strong written and oral communication skills, including experience presenting at scientific conferences
- Experience in clinical neurodegeneration image analysis
- Experience in developing or customizing image analysis software
Benefits
- Company Bonus
- 401(k)
- Pension
- Vacation Benefits
- Medical, Dental & Vision
- Prescription Drug Benefits
- Flexible Spending Accounts
- Life Insurance
- Death Benefits
- Time Off
- Leave of Absence Benefits
- Employee Assistance Program
- Fitness Benefits
- Employee Clubs and Activities
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.